Sequential Bilateral Intravitreal Injection of GS010 (rAAV2/2-ND4) Separated by a 15-Day or a 3-Month Interval in Non-Human Primates: Good Safety and Immunogenicity Profile
MOLECULAR THERAPY（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined